Evidence map›Paper›PMID 32469699›Full record

ReviewCurrent neuropharmacology2020

The Dual Role of Microglia in Blood-Brain Barrier Dysfunction after Stroke.

Ruiqing Kang, Marcin Gamdzyk, Cameron Lenahan, Jiping Tang, Sheng Tan, John H Zhang

Open access · hybridAbstract readReview
In one paragraph

Review in Current neuropharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 1 synthesis or guideline pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Ruiqing KangDepartment of Physiology and Pharmacology, Loma Linda University, School of Medicine, Loma Linda, CA, USA
Marcin GamdzykDepartment of Physiology and Pharmacology, Loma Linda University, School of Medicine, Loma Linda, CA, USA
Cameron LenahanDepartment of Physiology and Pharmacology, Loma Linda University, School of Medicine, Loma Linda, CA, USA
Jiping TangDepartment of Physiology and Pharmacology, Loma Linda University, School of Medicine, Loma Linda, CA, USA
Sheng TanDepartment of Neurology, Zhujiang Hospital, Southern Medical University, Guangzhou, China
John H ZhangDepartment of Physiology and Pharmacology, Loma Linda University, School of Medicine, Loma Linda, CA, USA
Loma Linda University · USSouthern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is well-known that stroke is one of the leading causes of death and disability all over the world. After a stroke, the blood-brain barrier subsequently breaks down. The BBB consists of endothelial cells surrounded by astrocytes. Microglia, considered the long-living resident immune cells of the brain, play a vital role in BBB function. M1 microglia worsen BBB disruption, while M2 microglia assist in repairing BBB damage. Microglia can also directly interact with endothelial cells and affect BBB permeability. In this review, we are going to discuss the mechanisms responsible for the dual role of microglia in BBB dysfunction after stroke.

Indexed as

Blood-Brain BarrierStrokeAstrocytesEndothelial CellsHumansMicrogliaBlood-brain barrierendothelial cellsinflammationmicrogliapolarizationstroke

Identifiers

PMID32469699
PMCPMC7770642
OpenAlexW3031332948

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.